Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center
Diagnostics · 05.02.2025 · 15 (3) · 375
DOI: 10.3390/diagnostics15030375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 05.02.2025. Verfasst von Milica Brajkovic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Internal Medicine, University Clinical Hospital Center Bezanijska kosa, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Abstract (Originalsprache)
Background/Objectives: Obstructive sleep apnea (OSA) is a condition characterized by intermittent airway obstructions, leading to reduced oxygen levels and increased sympathetic nervous system activity. OSA can cause a range of health problems, including an increased risk of cardiovascular diseases and mortality. Galectin-3, a member of the galectin family, plays a significant role in inflammation and fibrosis, and studies show that it is elevated in various conditions, including heart and lung diseases. The aim of this study was to determine whether galectin-3 levels are related to the severity of sleep apnea.
Methods
A total of 191 participants from the University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia, between January 2023 and May 2024, were included in the analyses. All patients were hospitalized under suspicion of OSA, and they all underwent a polysomnography test. Various demographic, respiratory, laboratory, and clinical parameters were obtained. Correlations between numerical variables and galectin-3 were assessed by the Pearson or Spearman correlation coefficients. Univariate and multivariate linear regression models were used to assess the predictors of galectin-3 values. In all analyses, the significance level was set at 0.05.
Results
The mean age of the study participants was 56.2 years, mostly male (68.9%). Of the comorbidities, two-thirds of patients had hypertension (66.1%), 46.8% had hyperlipoproteinemia, and 21.1% had diabetes mellitus. Patients who had an AHI of more than fifteen events per hour more often had higher values of galectin-3. OSA severity had a significant positive correlation with galectin-3 (p = 0.014). In multivariate linear regression analysis, significant independent predictors of higher galectin-3 values were older age, presence of coronary disease, hypoventilation syndrome, higher BMI, NTproBNP, lactate, creatinine, lower LDL, and lower FEV1 (p < 0.05).
Conclusions
The present study demonstrated that galectin-3 is linked to the severity of OSA and plays a crucial role in inflammation induced by intermittent hypoxia in OSA. Further screening and interventions targeting galectin-3 could aid in preventing inflammatory diseases related to sleep disturbances.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Internal Medicine, University Clinical Hospital Center Bezanijska kosa, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
- Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Anesthesiology and Reanimation, University Clinical Hospital Center Bezanijska kosa, 11000 Belgrade, Serbia.
- Clinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Clinic for Cardiology, Military Medical Academy, 11000 Belgrade, Serbia.
ORCID-Profile: Sofija Nikolic, Viseslav Popadic, Novica Nikolic, Marija Brankovic, Mihailo Stjepanovic, Spasoje Popevic, Marija Zdravkovic
Förderung
- Wellcome Trust
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
Zitieren
APA
Brajkovic, M., Nikolic, S., Popadic, V., Milic, N., Rajovic, N., Nikolic, N., Sekulic, A., Brankovic, M., Stjepanovic, M., Popevic, S., Milovanovic, B., & Zdravkovic, M. (2025). Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center. Diagnostics, 15(3), 375. https://doi.org/10.3390/diagnostics15030375
Vancouver
Brajkovic M, Nikolic S, Popadic V, Milic N, Rajovic N, Nikolic N, et al. Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center. Diagnostics. 2025;15(3):375. doi:10.3390/diagnostics15030375
BibTeX
@article{Brajkovic2025,
author = {Brajkovic, Milica and Nikolic, Sofija and Popadic, Viseslav and Milic, Natasa and Rajovic, Nina and Nikolic, Novica and Sekulic, Ana and Brankovic, Marija and Stjepanovic, Mihailo and Popevic, Spasoje and Milovanovic, Branko and Zdravkovic, Marija},
title = {Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {3},
pages = {375},
doi = {10.3390/diagnostics15030375}
}
EUVIMED